ARRAKIS THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 10 Oct 2025)
What this means for you
This application is over — abandoned 10 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90265729
- Mark type
- Design + words
- Filed
- 20 Oct 2020
- Published for opposition
- 25 Jan 2022
- Abandoned
- 10 Oct 2025
- Attorney of record
- Glenn A. Gundersen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, small-molecule drugs
Owner
- Arrakis Therapeutics, Inc, Waltham, MA, US
- Arrakis Therapeutics, Inc, Waltham, MA, US
Prosecution history
- 10 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 10 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 5 GRANTED
- 04 Sept 2024 — SOU EXTENSION 5 FILED
- 04 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 22 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2024 — SOU EXTENSION 4 GRANTED
- 21 Feb 2024 — SOU EXTENSION 4 FILED
- 21 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Sept 2023 — SOU EXTENSION 3 GRANTED
- 06 Sept 2023 — SOU EXTENSION 3 FILED
- 06 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 07 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED